You are here
MBC & NSCLC: Let's Talk about Disease Control
Sat 26 Sept / 19:00 - 20:30 / Lehar 3
What is the treatment goal in metastatic disease? Suppressing the tumour? Controlling the disease?
This is a very relevant question in today’s management of metastatic breast cancer and non-small cell lung cancer that a distinguished faculty addressed during an Official Satellite Symposium sponsored by Pierre Fabre Médicament at the 2015 European Cancer Congress.
During this meeting, the faculty addressed practical issues, such as maintenance therapy, optimal schedules, based both upon published clinical evidence and their own practice.
M. Aapro (Switzerland)Welcome and presentation of the agenda by the co-chairman Dr. Matti Aapro
M. O'Brien (United Kingdom)Focus on the definition of disease control, its relevance in the metastatic setting and its evolving role in drugs development...
G. Milano (France)The view of the pharmacologist Dr. Gérard Milano on Tumour Control and on the mechanism of action of Metronomic Chemotherapy
M.E. Cazzaniga (Italy)Presentation by the Dr. Marina Cazzaniga of the current and futures strategies to optimise disease control in Metastatic Breast Cancer
F. Grossi (Italy)Presentation by the Dr. Francesco Grossi of the current and futures strategies to optimise disease control in NSCLC
M. Aapro (Switzerland)Conclusion by Dr. Matti Aapro on new avenues under development to achieve Optimal Disease Control and maximize patient benefit